Last reviewed · How we verify
Nasal Sprays
Nasal Sprays is a Small molecule drug developed by University of Electronic Science and Technology of China. It is currently FDA-approved.
Nasal sprays deliver pharmaceutical agents directly to the nasal mucosa for local or systemic absorption.
At a glance
| Generic name | Nasal Sprays |
|---|---|
| Sponsor | University of Electronic Science and Technology of China |
| Modality | Small molecule |
| Phase | FDA-approved |
Mechanism of action
Nasal sprays are a delivery formulation rather than a specific drug entity. They work by depositing medication onto the nasal epithelium, which has high vascularity and permeability, allowing for rapid absorption into systemic circulation or local therapeutic effect in the nasal cavity and upper respiratory tract. The specific mechanism depends entirely on the active pharmaceutical ingredient contained within the spray formulation.
Approved indications
Common side effects
- Nasal irritation
- Epistaxis
- Headache
- Taste disturbance
Key clinical trials
- Efficacy and Safety of Fully Resorbable Sinus Drug-eluting Stents in Patients With Eosinophilic Chronic Rhinosinusitis With Nasal Polyps After Surgery: A Prospective, Randomized Controlled Trial (NA)
- Vaccine Pandemic Preparedness Through Airway Immunology Characterization (EARLY_PHASE1)
- Exosomes Effect on Visual Function in CVI
- A Study of Lebrikizumab (LY3650150) in Participants With Chronic Rhinosinusitis and Nasal Polyps Treated With Intranasal Corticosteroids (CONTRAST-NP) (PHASE3)
- Efficacy and Safety of 186 mcg of OPN-375 Nasal Spray Twice a Day (BID) in Adolescents With Chronic Rhinosinusitis Without Nasal Polyps (PHASE3)
- A Study Evaluating the Safety, Tolerability and Pharmacokinetics of ASY202 in Healthy Adults (PHASE1)
- Cromoglicate Adjunctive Therapy for Outpatients With Schizophrenia (PHASE1, PHASE2)
- Evaluation of MIG-SPRAY Treatment on Migraine (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Nasal Sprays CI brief — competitive landscape report
- Nasal Sprays updates RSS · CI watch RSS
- University of Electronic Science and Technology of China portfolio CI
Frequently asked questions about Nasal Sprays
What is Nasal Sprays?
How does Nasal Sprays work?
Who makes Nasal Sprays?
What development phase is Nasal Sprays in?
What are the side effects of Nasal Sprays?
Related
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing